Comparison of the effects of an ACE inhibitor and αβ blocker on the progression of renal failure with left ventricular Hypertrophy: Preliminary report

Hypertension Research

Volumn 24, Issue 2, 2001, Pages 153-158

  Suzuki, H ^a   Moriwaki, K ^a   Kanno, Y ^a   Nakamoto, H ^a   Okada, H ^a   Chen, X M ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Arotinolol; Benazepril; Left ventricular hypertrophy; Renal insufficiency

Indexed keywords

AMLODIPINE; AROTINOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZAZEPINES; BLOOD PRESSURE; COHORT STUDIES; CREATININE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENAL; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PILOT PROJECTS; PROPANOLAMINES; PROTEINURIA;

EID: 0035040238     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.24.153     Document Type: Article

References (27)

1. Report on management of renal failure in Europe, XXV, 1994: End stage renal disease and dialysis report
2. Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis
3. Left ventricular hypertrophy in hypertension: Stimuli, patterns, and consequencs
4. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure
5. Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure
6. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine
7. Carvedilol
8. Control of blood pressure and prevention of end-organ damage in patients with accelerated hypertension by combination with arotinolol and extended release nifedipine
9. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent
10. Pharmacological profile of beta-adrenoceptor blockers with vasodilating properties, especially carvedilol rationale for clinical use
11. Maximizing cardio-renal benefits: Achieve blood pressure goals
12. Echocardiographic determination of left ventricular mass in man
13. Randomized placebo controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
14. Achievement and safety of a low blood pressure goal in chronic renal disease: The modification of diet in renal disease study group
15. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
16. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
17. Prediction of creatinine clearance from serum creatinine
18. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril (REIN follow-up trial)
19. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies
20. Nifedipine and arotinolol in combination for accelerated-malignant hypertension: Results of one year follow-up
21. Effects of long-term therapy with arotinolol on blood pressure and renal function in hypertensive patients with chronic renal failure
22. Single-nephron adaptations to partial renal ablation in cats
23. Effects of enalapril on mortality in severe congestive heart failure; results of the cooperative North Scandinavian enalapril survival study (CONSEN SUS)
24. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction
25. Predictors of deceased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: Results of the studies of left ventricular dysfunction